INTECH Investment Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
INTECH Investment Management's DGX Position: Q2 2026 in Review
INTECH Investment Management increased its Quest Diagnostics (DGX) stake by 2.4% in Q2 2026, buying an estimated $94.4K and bringing the position to 20,375 shares worth $4.32M. The position accounts for 0.04% of the portfolio, ranked #416.
INTECH Investment Management first reported a position in DGX in Q2 2022 and has held it in 17 quarters since. The position peaked at $56.4M in Q4 2022. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- INTECH Investment Management held 20,375 shares of Quest Diagnostics worth $4.32M as of Q2 2026.
- INTECH Investment Management bought 481 Quest Diagnostics shares in Q2 2026, an estimated $94.4K.
- Quest Diagnostics made up 0.04% of INTECH Investment Management's portfolio in Q2 2026, its #416 holding.
- INTECH Investment Management first reported a position in Quest Diagnostics in Q2 2022 and has held it in 17 quarters since.
- INTECH Investment Management's Quest Diagnostics position peaked at $56.4M in Q4 2022.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.